Minu Chaudhuri

Dr. Minu Chaudhuri

Microbiology, Immunology, and Physiology, Meharry Medical College, Nashville, TN 37208, USA

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2006 in Trends in Parasitology
Verified
Journal Article
Closed access
Minu ChaudhuriMinu Chaudhuri
Minu Chaudhuri
RORobert Daniel Ott
Robert Daniel Ott
GHGeorge C. Hill
George C. Hill

1 May 2008 in Molecular and Biochemical Parasitology
Verified
Journal Article
Closed access
USUjjal K. Singha
Ujjal K. Singha
EPEmmanuel Peprah
Emmanuel Peprah
SWShuntae Williams
Shuntae Williams
RWRobert Walker
Robert Walker
LSLipi Saha
Lipi Saha
Minu ChaudhuriMinu Chaudhuri
Minu Chaudhuri

1 April 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
USUjjal K. Singha
Ujjal K. Singha
VHVaNae Hamilton
VaNae Hamilton
MDMelanie R. Duncan
Melanie R. Duncan
EWEbony Weems
Ebony Weems
MTManish K. Tripathi
Manish K. Tripathi
Minu ChaudhuriMinu Chaudhuri
Minu Chaudhuri
Translocases of mitochondrial inner membrane (TIMs) are multiprotein complexes. The only Tim component so far characterized in kinetoplastid parasites such as Trypanosoma brucei is Tim17 (TbTim17), which is essential for cell survival and mitochondrial protein import. Here, we report that TbTim17 is present in a protein complex of about 1,100 kDa, which is much larger than the TIM complexes found in fungi and mammals. Depletion of TbTim17 in T. brucei impairs the mitochondrial import of cytochrome oxidase subunit IV, an N-terminal signal-containing protein. Pretreatment of isolated mitoplasts with the anti-TbTim17 antibody inhibited import of cytochrome oxidase subunit IV, indicating a direct involvement of the TbTim17 in the import process. Purification of the TbTim17-containing protein complex from the mitochondrial membrane of T. brucei by tandem affinity chromatography revealed that TbTim17 associates with seven unique as well as a few known T. brucei mitochondrial proteins. Depletion of three of these novel proteins, i.e. TbTim47, TbTim54, and TbTim62, significantly decreased mitochondrial protein import in vitro. In vivo targeting of a newly synthesized mitochondrial matrix protein, MRP2, was also inhibited due to depletion of TbTim17, TbTim54, and TbTim62. Co-precipitation analysis confirmed the interaction of TbTim54 and TbTim62 with TbTim17 in vivo. Overall, our data reveal that TbTim17, the single homolog of Tim17/22/23 family proteins, is present in a unique TIM complex consisting of novel proteins in T. brucei and is critical for mitochondrial protein import.

13 September 2018 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
WZWenxu Zhou
Wenxu Zhou
Anjan DebnathAnjan Debnath
Anjan Debnath
GJGareth Jennings
Gareth Jennings
HHHye Jee Hahn
Hye Jee Hahn
BVBoden H Vanderloop
Boden H Vanderloop
LPLarissa M Podust
Larissa M Podust
Naegleria fowleri is a free-living amoeba that can also act as an opportunistic pathogen causing severe brain infection, primary amebic meningoencephalitis (PAM), in humans. The high mortality rate of PAM (exceeding 97%) is attributed to (i) delayed diagnosis, (ii) lack of safe and effective anti-N. fowleri drugs, and (iii) difficulty of delivering drugs to the brain. Our work addresses identification of new molecular targets that may link anti-Naegleria drug discovery to the existing pharmacopeia of brain-penetrant drugs. Using inhibitors with known mechanism of action as molecular probes, we mapped the sterol biosynthesis pathway of N. fowleri by GC-MS analysis of metabolites. Based on this analysis, we chemically validated two enzymes downstream to CYP51, sterol C24-methyltransferase (SMT, ERG6) and sterol Δ8−Δ7 -isomerase (ERG2), as potential therapeutic drug targets in N. fowleri. The sterol biosynthetic cascade in N. fowleri displayed a mixture of canonical features peculiar to different domains of life: lower eukaryotes, plants and vertebrates. In addition to the cycloartenol→ergosterol biosynthetic route, a route leading to de novo cholesterol biosynthesis emerged. Isotopic labeling of the de novo-synthesized sterols by feeding N. gruberi trophozoites on the U13C-glucose-containing growth medium identified an exogenous origin of cholesterol, while 7-dehydrocholesterol (7DHC) had enriched 13C-content, suggesting a dual origin of this metabolite both from de novo biosynthesis and metabolism of scavenged cholesterol. Sterol homeostasis in Naegleria may be orchestrated over the course of its life-cycle by a “switch” between ergosterol and cholesterol biosynthesis. By demonstrating the growth inhibition and synergistic effects of the sterol biosynthesis inhibitors, we validated new, potentially druggable, molecular targets in N. fowleri. The similarity of the Naegleria sterol Δ8−Δ7 -isomerase to the human non-opioid σ1 receptor, implicated in human CNS conditions such as addiction, amnesia, pain and depression, provides an incentive to assess structurally diverse small-molecule brain-penetrant drugs targeting the human receptor for anti-Naegleria activity. Sterols are important constituents of cell membranes. In a unicellurar organism, such as the human pathogen N. fowleri, the cell membrane delineates the physical boundaries of the cell and mediates interactions of the organism with its environment. N. fowleri is a free-living amoeba that may infect the human brain causing a fulminant infection called primary amebic meningoencephalitis (PAM). PAM has resulted in death in >97% of reported cases. Understanding the molecular and cellular biology of N. fowleri will facilitate the rational development of new therapeutic interventions. Using inhibitors targeting different enzymatic steps in the sterol biosynthesis pathway, we mapped metabolic intermediates and delineated the biosynthetic routes contributing to N. fowleri sterol homeostasis. An array of sterol molecules suggests that two different sterol types, ergosterol-like and cholesterol-like sterols, co-exist and may be dynamically regulated in N. fowleri. Disruption of sterol biosynthesis by drug candidates was detrimental to N. fowleri. Drugs targeting three different enzymatic steps resulted in growth inhibition effect. This effect was amplified when drugs targeting different enzymes were combined. The observed synergistic effect of these drugs lowers the individual drug concentrations required for biological activity including delivering anti-PAM drugs across the blood-brain-barrier.

1 September 2009 in Eukaryotic Cell
Verified
Journal Article
Closed access
USUjjal K. Singha
Ujjal K. Singha
SSShvetank Sharma
Shvetank Sharma
Minu ChaudhuriMinu Chaudhuri
Minu Chaudhuri
Porin is the most abundant outer membrane (OM) protein of mitochondria. It forms the aqueous channel on the mitochondrial OM and mediates major metabolite flux between mitochondria and cytosol. Mitochondrial porin in Trypanosoma brucei , a unicellular parasitic protozoan and the causative agent of African trypanosomiasis, possesses a β-barrel structure similar to the bacterial OM porin OmpA. T. brucei porin (TbPorin) is present as a monomer as well as an oligomer on the mitochondrial OM, and its expression is developmentally regulated. In spite of its distinct structure, the TbPorin function is similar to those of other eukaryotic porins. TbPorin RNA interference (RNAi) reduced cell growth in both procyclic and bloodstream forms. The depletion of TbPorin decreased ATP production by inhibiting metabolite flux through the OM. Additionally, the level of trypanosome alternative oxidase (TAO) decreased, whereas the levels of cytochrome-dependent respiratory complexes III and IV increased in TbPorin-depleted mitochondria. Furthermore, the depletion of TbPorin reduced cellular respiration via TAO, which is not coupled with oxidative phosphorylation, but increased the capacity for cyanide-sensitive respiration. Together, these data reveal that TbPorin knockdown reduced the mitochondrial ATP level, which in turn increased the capacity of the cytochrome-dependent respiratory pathway (CP), in an attempt to compensate for the mitochondrial energy crisis. However, a simultaneous decrease in the substrate-level phosphorylation due to TbPorin RNAi caused growth inhibition in the procyclic form. We also found that the expressions of TAO and CP proteins are coordinately regulated in T. brucei according to mitochondrial energy demand.

1 September 2015 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
USUjjal K. Singha
Ujjal K. Singha
VHVaNae Hamilton
VaNae Hamilton
Minu ChaudhuriMinu Chaudhuri
Minu Chaudhuri
Trypanosoma brucei, the causative agent of human African trypanosomiasis, possesses non-canonical mitochondrial protein import machinery. Previously, we characterized the essential translocase of the mitochondrial inner membrane (TIM) consisting of Tim17 in T. brucei. TbTim17 is associated with TbTim62. Here we show that TbTim62, a novel protein, is localized in the mitochondrial inner membrane, and its import into mitochondria depends on TbTim17. Knockdown (KD) of TbTim62 decreased the steady-state levels of TbTim17 post-transcriptionally. Further analysis showed that import of TbTim17 into mitochondria was not inhibited, but its half-life was reduced >4-fold due to TbTim62 KD. Blue-native gel electrophoresis revealed that TbTim62 is present primarily in ∼150-kDa and also in ∼1100-kDa protein complexes, whereas TbTim17 is present in multiple complexes within the range of ∼300 to ∼1100 kDa. TbTim62 KD reduced the levels of both TbTim62 as well as TbTim17 protein complexes. Interestingly, TbTim17 was accumulated as lower molecular mass complexes in TbTim62 KD mitochondria. Furthermore, depletion of TbTim62 hampered the assembly of the ectopically expressed TbTim17–2X-myc into TbTim17 protein complex. Co-immunoprecipitation analysis revealed that association of TbTim17 with mHSP70 was markedly reduced in TbTim62 KD mitochondria. All together our results demonstrate that TbTim62, a unique mitochondrial protein in T. brucei, is required for the formation of a stable TbTim17 protein complex. TbTim62 KD destabilizes this complex, and unassembled TbTim17 degrades. Therefore, TbTim62 acts as a novel regulatory factor to maintain the levels of TIM in T. brucei mitochondria.